European Society of Toxicology In Vitro > News > The 10th Annual ASCCT Meeting will be taking place virtually October 12th – 14th, 2021!
4 June 2021

The 10th Annual ASCCT Meeting will be taking place virtually October 12th – 14th, 2021!

We are excited to announce that the 10th Annual ASCCT Meeting will be taking place virtually October 12th – 14th, 2021! Visit our event page for additional information.

This year’s theme will be Practical applications of new tools in toxicology, and abstracts for oral and poster presentations are now invited to be submitted. Any submissions related to in vitro and in silico toxicology, broadly defined and including science, policy, and regulatory topics, are welcome.

Five oral sessions will focus on the following categories:

  1. 21st-Century challenges for 21st-Century Toxicology, featuring plenary speaker Patience Browne, OECD
  2. Practical applications of Omics, featuring plenary speaker Carole Yauk, University of Ottawa
  3. Applying Artificial Intelligence in Toxicology, featuring plenary speaker Thomas Hartung, Johns Hopkins University/CAAT
  4. New Approaches to Validation, featuring plenary speakers Andrew Worth and Sandra Coecke, EU Joint Research Centre
  5. Free communications 

The meeting will also feature poster sessions and other engagement opportunities.

If you would like to join the organizing committee to help organize the meeting and share your ideas, please contact the Secretary at ksullivan@ascctox.org.

Related content

ESTIV Poster Award at the 2021 edition of the JRC Summer School has been granted to Sabrina Madiedo-Podvršan .

Congratulations to the ESTIV Poster Award at the 2021 JRC Summer School on the Non-Animal Approaches in Science!

The new Biomedical research report from ECVAM: Tackling neurodegenerative diseases with more human relevant research

To promote more human relevant research, the JRC’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) led a study to review advanced non-animal models used in the field of neurodegenerative diseases, specifically for Parkinson’s and Alzheimer’s.

Corporate Members

mattek in Vitro Life Science Laboratories

Affiliated Societies

Invitrom Celltox IVTS

Memorandum of Understanding